Endocrinology / diabetes clinical trials recruiting in Illinois

257 recruiting endocrinology / diabetes trials match in Illinois. Showing 20.

• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseRecruiting

  Phase 2 · Novo Nordisk A/S · Ibaraki

• Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesRecruiting

  Phase 4 · VA Office of Research and Development · Hines, Illinois

• A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult ParticipantsRecruiting

  Phase 2 / Phase 3 · AbbVie · Chicago, Illinois

• RCT Glargine vs NPH for Treatment of DM in PregnancyRecruiting

  Phase 3 · Loyola University · Maywood, Illinois

• Caloric Restriction and Activity to Reduce Chemoresistance in B-ALLRecruiting

  Phase 2 · Etan Orgel · Chicago, Illinois

• The Myelin Disorders Biorepository ProjectRecruiting

  N/A · Children's Hospital of Philadelphia · Chicago, Illinois

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Chicago, Illinois

• TTX-080 HLA-G Antagonist in Subjects With Advanced CancersRecruiting

  Phase 1 · Tizona Therapeutics, Inc · Denver, Colorado

• A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone TreatmentRecruiting

  Phase 2 · BioMarin Pharmaceutical · Chicago, Illinois

• Integrated Cancer Repository for Cancer ResearchRecruiting

  N/A · University of Nebraska · Aurora, Illinois

• A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightRecruiting

  Phase 2 · Eli Lilly and Company · Chicago, Illinois

• Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney DiseaseRecruiting

  Phase 2 · Regeneron Pharmaceuticals · Chicago, Illinois

• An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye DiseaseRecruiting

  Phase 2 · Amgen · Orland Park, Illinois

• Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical CancerRecruiting

  Phase 2 · National Cancer Institute (NCI) · Chicago, Illinois

• Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsRecruiting

  Phase 1 · Xencor, Inc. · Chicago, Illinois

• Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot UlcersRecruiting

  N/A · LifeNet Health · Decatur, Illinois

• Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )Recruiting

  Phase 3 · Revolution Medicines, Inc. · Chicago, Illinois

• Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot UlcersRecruiting

  Phase 1 / Phase 2 · Eluciderm Inc · O'Fallon, Illinois

• Pancreatic Cancer Detection ConsortiumRecruiting

  N/A · City of Hope Medical Center · Peoria, Illinois

• A Study of Pitolisant in Patients With Prader-Willi SyndromeRecruiting

  Phase 3 · Harmony Biosciences Management, Inc. · Chicago, Illinois

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.